ISB 2001

DB18570InvestigationalProtein Based Therapies

ISB 2001 is a T cell-engaging antibody that targets BCMA, CD38, and CD3.

Mechanism: Pharmacologically active on T-cell surface glycoprotein CD3 epsilon chain, ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1, and Tumor necrosis factor receptor superfamily member 17
Curator reviewed
Code names: ABBV-2001 · ISB-2001

Resolves to

Targets

What you can answer from here — as of July 09, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with ISB 2001, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.